Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19918168 | 0.72 | TSHR (0.33) | TSHR | |
| SCHEMBL7189233 | 0.69 | — | — | |
| SCHEMBL276809 | 0.67 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL276740 | 0.67 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL277461 | 0.67 | TSHR (0.30) | TSHR | |
| SCHEMBL59816 | 0.67 | — | — | |
| SCHEMBL5480721 | 0.65 | — | — | |
| SCHEMBL3560845 | 0.65 | — | — | |
| SCHEMBL150135 | 0.64 | — | — | |
| SCHEMBL11868739 | 0.62 | TDP1 (0.38) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103316671-B | Organic carbon monoxide-releasing molecules prepares method and the catalytic applications thereof of palladium carbon | SHAANXI NORMAL UNIVERSITY (CN) | 2015-12-23 | — | — | CN | claimed |
| CN-103316671-A | Method for preparing palladium carbon by using organic carbon monoxide releasing molecule (CORM) and catalytic application of method | UNIV SHAANXI NORMAL | 2013-09-25 | — | — | CN | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-0641356-B1 | INHIBITORS OF 5-ALPHA-TESTOSTERONE REDUCTASE | GLAXO WELLCOME INC (US) | 1998-04-22 | — | — | EP | claimed |
| US-5543406-A | TREATING ANDROGEN RESPONSIVE OR MEDIATED DISEASE | GLAXO WELLCOME, INC. (US) | 1996-08-06 | — | — | US | claimed |
| US-5476743-A | Thermoplastic resin, a charge director, a liquid component, an additive selected from cyclic carbonates, cyclic sulfones, cyclic sulfoxides and organic amides, pigments, and a charge adjuvant | XEROX CORPORATION (US) | 1995-12-19 | — | — | US | claimed |
| WO-1993013124-A1 | INHIBITORS OF 5-ALPHA-TESTOSTERONE REDUCTASE | GLAXO INC. (US) | 1993-07-08 | — | — | WO | claimed |
| EP-4622953-A1 | PREPARATION OF 4-CYANOBENZOYL CHLORIDES FROM ALKALI METAL 4-CARBAMOYL-BENZOATES | BASF SE (DE) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024128000-A1 | ISOPOLYOXOTUNGSTATE SALT COMPOUND, SOLVATE THEREOF OR MIXTURE OF SAID COMPOUND AND SOLVATE, AND METHOD FOR PRODUCING SAID COMPOUND, SOLVATE OR MIXTURE | 東京応化工業株式会社 | 2024-06-20 | — | — | WO | disclosed |
| US-11938233-B2 | 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof | UNIVERSITÄTSKLINIKUM REGENSBURG (DE) | 2024-03-26 | — | — | US | disclosed |
| WO-2024043261-A1 | AZO COMPOUND OR SALT THEREOF, AND POLARIZING FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE COMPRISING SAME | 日本化薬株式会社 | 2024-02-29 | — | — | WO | disclosed |
| CN-114026199-B | Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof | 日本化药株式会社 | 2023-12-26 | — | — | CN | disclosed |
| EP-0064878-A1 | Novel aniline derivatives, process for preparing the same and cardiotonic compositions containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1982-11-17 | — | — | EP | disclosed |
| US-4269998-A | Production of dialkyl formamide | UOP INC. (US) | 1981-05-26 | — | — | US | disclosed |
| US-4016153-A | Monoazo dyestuff mixtures derived from 2-amino-5-nitro-thiazole and bis-hydroxyalkylamino acklanilides reacted with acid halides and amides | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1977-04-05 | — | — | US | disclosed |
| US-4008212-A | Monoazo dye mixtures derived from 7-amino-4-nitrobenzotriazole and bis-hydroxyalkylamino acylanilides reacted with acid halides and amides | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-3949088-A | Substituted phenoxy propanol amines used for treating cardiovascular diseases | SAMUELSSON BENNY ROGER | 1976-04-06 | — | — | US | disclosed |
| US-3935016-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolone couplers | FUJI PHOTO FILM COMPANY, LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11938233-B2 | 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof | DHPS, SQLE, CYP51A1 | TSHR 4635/4885TDP1 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.